Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
NACompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
September 30, 2007
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Conditions
Transitional Carcinoma of Urinary Bladder
Interventions
DRUG
BCG, Interferon
Chemotherapy
All Listed Sponsors
lead
King Faisal Specialist Hospital & Research Center
OTHER
NCT00539773 - Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder | Biotech Hunter | Biotech Hunter